Table 3.
Sample | Candidate Gene Name | Chromosome | Genomic Variation | cDNA Variation | dbSNP | Allele Frequency | Inheritance | Genotype | Function | ACMG | Phenotype * |
---|---|---|---|---|---|---|---|---|---|---|---|
48 | PLCE1 | 10 | g.95987105A>G | c.1852A>G | rs200180170 | 0.0004975 | AR | Het | Missense | VUS | Unknown ESRD |
60 | MYO1E | 15 | g.59450575G>A | c.2789C>T | - | 0.0 | AR | Het | Missense | VUS | Unknown ESRD |
92 | COQ6 | 14 | g.74428075T>C | c.1091T>C | rs747211443 | 0.00001548 | AR | Het | Missense | VUS | Unknown ESRD |
170 | PLCE1 | 10 | g.96013948G>C | c.3281G>C | rs61732523 | 0.0002567 | AR | Het | Missense | Pathogenic (VUS meaning) | Unknown ESRD |
g.95931087G>T | c.1643G>T | rs17417407 | 0.1667 | AR | Het | Missense | Benign (VUS meaning) | ||||
191 | NPHS1 | 19 | g.36340506A>C | c.658T>G | rs115333628 | 0.001827 | AR | Het | Missense | VUS/conflicting interpretation of pathogenicity based on ClinVar | Unknown ESRD |
g.36342212C>T | c.349G>A | rs3814995 | 0.3102 | AR | Het | Missense | Benign |
* ESRD: End Stage Renal Disease; AR: Autosomal Recessive; Het: Heterozygous; VUS meaning: it has been reported to manifest the final explanation of manual curation during the prioritization process, and is not only expressed in online tools of pathogenicity, such as ACMG and others.